Research update- June 2022
There are exciting things ahead with the upcoming launch of our new 5-year strategy and a growing research team
The Big Love Fund
We are privileged to launch the BIG LOVE FUND, inspired by the story of Luke Wiltshire, on what would have been Luke’s 24th birthday. We have launched this new fund to help support more children and young people like Luke.
Solving Kids' Cancer UK Response to Debate on Childhood Cancer Outcomes
On 25th April Caroline Dinenage MP for Gosport brought forward a debate on Childhood Cancer Outcomes to the House of Commons. We are grateful that this ever-important topic has been brought to the House.
Bent's Garden & Homes raises over £44,000 for Solving Kids' Cancer UK as their Charity of the Year
We are so grateful to our 2021 Charity of the Year partners Bent’s Garden & Homes, their colleagues and customers for raising an astonishing £44,597!
Chair of Trustees leads patient advocate authorship on important special report discussing the use of high-dose chemotherapy in the treatment of high-risk neuroblastoma.
This week five patient advocate authors, led by SKC Chair Nick Bird, were published in the leading journal Pediatric Blood and Cancer.
Maintenance Options After Frontline Treatment – A Personal Reflection on Decision-Making
Welcome to the first blog edition from our Family Support Service. Parent-led, our dedicated Family Support Service takes pride in being there for families affected by neuroblastoma.
Solving Kids' Cancer joins One Cancer Voice in calls for a robust 10-year Cancer Plan
On February 4th 2022, World Cancer Day, Sajid Javid announced the launch of a 'war on cancer' - signalling a renewed ambition and prioritisation of tackling cancer.
SKC UK CEO and Chair of Trustees meet with Batley and Spen MP Kim Leadbeater
This week Gail Jackson and Nick Bird were invited to speak with MP for Batley and Spen Kim Leadbeater in Westminster following her recent support for driving more research into childhood cancers including neuroblastoma.
Research update- March 2022
In 2022 we are aiming to improve and increase patient representation in neuroblastoma research. This spotlight on research advocacy explains exactly what that means and how we will achieve it.
